• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体外受精(IVF)程序中,使用布舍瑞林在使用外源性促性腺激素进行卵巢刺激之前抑制垂体 - 卵巢功能。

Use of buserelin in an IVF programme for pituitary-ovarian suppression prior to ovarian stimulation with exogenous gonadotrophins.

作者信息

Ibrahim Z H, Matson P L, Buck P, Critchlow J D, Newman M C, Horne G, Hughes S, Lieberman B A

机构信息

Regional IVF Unit, St. Mary's Hospital, Whitworth Park, Manchester, UK.

出版信息

Hum Reprod. 1990 Apr;5(3):258-62. doi: 10.1093/oxfordjournals.humrep.a137084.

DOI:10.1093/oxfordjournals.humrep.a137084
PMID:2112554
Abstract

Daily s.c. injections of buserelin were commenced in the mid-luteal phase of the preceding cycle in 118 women undergoing in-vitro fertilization (IVF) and embryo transfer. Ovarian and pituitary suppression was said to have been adequately achieved when serum oestradiol was less than 50 pg/ml, serum LH less than 2.0 IU/l, no ovarian cysts greater than or equal to 10 mm diameter were present and menstruation had occurred. Nine groups of women were retrospectively identified after the administration of buserelin for 12 days according to whether pituitary and ovarian suppression had been achieved or not, and the reason for extended buserelin treatment prior to ovarian stimulation. Upon adequate suppression, patients were grouped in terms of the duration of exposure to buserelin, and ovarian stimulation was then started by daily injections of human menopausal gonadotrophin. There appeared to be no differences in the ovarian response for women down-regulated by day 12, 19 or greater than or equal to 26 days; those women requiring extended buserelin treatment did equally well compared to those women down-regulating quickly, in terms of number of oocytes recovered and fertilization rate. Clinical pregnancy rates per embryo transfer were 27/68(40%), 8/33(26%) and 4/17(24%) for those women down-regulated by days 12, 19 or greater than or equal to 26 respectively, and were not significantly different.

摘要

对118名接受体外受精(IVF)和胚胎移植的女性,在前一周期的黄体中期开始每日皮下注射布舍瑞林。当血清雌二醇低于50 pg/ml、血清促黄体生成素低于2.0 IU/l、不存在直径大于或等于10 mm的卵巢囊肿且已发生月经时,据说已充分实现了卵巢和垂体抑制。根据是否实现垂体和卵巢抑制以及在卵巢刺激前延长布舍瑞林治疗的原因,在给予布舍瑞林12天后对九组女性进行回顾性鉴定。在充分抑制后,根据布舍瑞林暴露时间对患者进行分组,然后通过每日注射人绝经期促性腺激素开始卵巢刺激。在第12天、第19天或大于或等于26天被下调的女性中,卵巢反应似乎没有差异;就回收的卵母细胞数量和受精率而言,那些需要延长布舍瑞林治疗的女性与那些快速下调的女性表现同样良好。对于分别在第12天、第19天或大于或等于26天被下调的女性,每次胚胎移植的临床妊娠率分别为27/68(40%)、8/33(26%)和4/17(24%),且无显著差异。

相似文献

1
Use of buserelin in an IVF programme for pituitary-ovarian suppression prior to ovarian stimulation with exogenous gonadotrophins.在体外受精(IVF)程序中,使用布舍瑞林在使用外源性促性腺激素进行卵巢刺激之前抑制垂体 - 卵巢功能。
Hum Reprod. 1990 Apr;5(3):258-62. doi: 10.1093/oxfordjournals.humrep.a137084.
2
Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.在体外受精-胚胎移植计划中,醋酸布舍瑞林诱导垂体脱敏期间血清促卵泡生成素与促黄体生成素比值对卵巢对外源性促性腺激素反应的影响。
Hum Reprod. 1996 Aug;11(8):1615-9. doi: 10.1093/oxfordjournals.humrep.a019456.
3
Serum inhibin as an index of ovarian function in women undergoing pituitary suppression and ovarian stimulation in an in vitro fertilization program.血清抑制素作为体外受精程序中接受垂体抑制和卵巢刺激的女性卵巢功能指标。
Horm Res. 1991;35(5):173-7. doi: 10.1159/000181897.
4
Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme.参与体外受精项目的女性在使用布舍瑞林和人绝经期促性腺激素治疗后,于黄体期用人绒毛膜促性腺激素进行支持治疗的试验。
BMJ. 1989 Jun 3;298(6686):1483-6. doi: 10.1136/bmj.298.6686.1483.
5
Failure to improve ovarian response by combined gonadotropin-releasing hormone agonist and gonadotropin therapy.
Gynecol Obstet Invest. 1990;29(3):192-6. doi: 10.1159/000293376.
6
Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.在使用促性腺激素刺激之前,用促性腺激素释放激素类似物进行抑制:三种方案的比较。
Gynecol Obstet Invest. 1989;28(1):31-4. doi: 10.1159/000293495.
7
Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.采用促性腺激素释放激素激动剂联合人绝经期促性腺激素控制的体外受精卵巢过度刺激。
Hum Reprod. 1986 Jan;1(1):15-9. doi: 10.1093/oxfordjournals.humrep.a136334.
8
Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment.垂体抑制后卵巢基质血流速度测量在预测卵巢反应性及体外受精治疗结局中的价值。
Fertil Steril. 1999 Jan;71(1):22-9. doi: 10.1016/s0015-0282(98)00406-3.
9
Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study.皮下注射戈舍瑞林与鼻内注射布舍瑞林用于体外受精患者垂体降调节的随机对照研究。
Hum Reprod. 1993 Dec;8(12):2052-5. doi: 10.1093/oxfordjournals.humrep.a137980.
10
Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?对于有发生卵巢过度刺激综合征风险的女性,是否有必要继续使用促性腺激素释放激素激动剂(GnRHa)?
Hum Reprod. 1992 Sep;7(8):1090-3. doi: 10.1093/oxfordjournals.humrep.a137798.

引用本文的文献

1
Ova Retrieval for IVF in the Light of Islamic Sharī'ah Laws in Pakistan.巴基斯坦伊斯兰教法视角下的体外受精取卵
J Relig Health. 2023 Apr;62(2):778-796. doi: 10.1007/s10943-022-01690-7. Epub 2022 Nov 28.
2
Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles.体外受精中卵泡期降调节期间的卵巢活动与高龄产妇及后续周期的高复发率相关。
J Assist Reprod Genet. 1995 May;12(5):301-4. doi: 10.1007/BF02213708.
3
The titer of sperm agglutinating activity remains constant in women during ovarian stimulation for IVF.
J Assist Reprod Genet. 1994 Nov;11(10):530-1. doi: 10.1007/BF02216033.
4
Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.在有卵巢过度刺激综合征风险的女性中使用布舍瑞林和低剂量人绝经期促性腺激素进行体外受精。
J Assist Reprod Genet. 1995 Apr;12(4):252-7. doi: 10.1007/BF02212927.